Natco shares gain after antidiabetic drug partner Mylan, Novo Nordisk settle patent litigation

Natco Pharma shares rise 3% as partner Mylan settles U.S. patent litigation with Novo Nordisk for generic Ozempic … law passes forcing it to pay for …